Ovary Removal Before Menopause Linked to Cognitive Impairment, Dementia Risk

Translate to Spanish or other 102 languages!

A new study shows that ovary removal before menopause is linked to decreased white matter in the brain later in life. Image for illustration purposes
A new study shows that ovary removal before menopause is linked to decreased white matter in the brain later in life. Image for illustration purposes
- Advertisement -
  • A new study examined the brains of females who underwent full ovary removal before going through menopause.
  • Sometimes, females must undergo this type of procedure to treat conditions such as ovarian cancer or endometriosis.
  • The study’s findings show that females who undergo ovary removal before menopause have a decrease in white matter in their brains later in life. 
  • A decrease in white matter is linked to cognitive impairment.

A new study examined the cognitive effects of ovary removal in females.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/ovary-removal-before-menopause-cognitive-decline-dementia-risk?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-06-28&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

Why Science Says to Ditch Hydrogen Peroxide for Wounds

Growing up, you may have heard that you should treat open wounds with hydrogen peroxide, but that’s no longer the case.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- Advertisement -